Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large-Reference-Cited by-同舟云学术

Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large

Published:2013-07 Issue:11 Volume:49 Page:2542-2554
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Friesen Claudia,Roscher Mareike,Hormann Inis,Leib Oliver,Marx Sebastian,Moreno Josue,Miltner Erich

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Gene expression profiling in acute myeloid leukaemia;de Jonge;Neth J Med,2011

2. Treatment strategies in acute myeloid leukemia;Han;Chin Med J (Engl),2011

3. Allogeneic hematopoietic cell transplantation for adult patients with acute myeloid leukemia;Stockerl-Goldstein,1999

4. Predicting the tumor response to radiotherapy using microarray analysis (Review);Ogawa;Oncol Rep,2007

5. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells;Friesen;Leukemia,1997

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles;Molecular Pharmaceutics;2023-08-22

2. Radionuclide Therapy of Leukemias and Multiple Myeloma;Nuclear Oncology;2022

3. Radionuclide Therapy of Leukemias and Multiple Myeloma;Nuclear Oncology;2022

4. Breaking the Silence of Tumor Response: Future Prospects of Targeted Radionuclide Therapy;Anti-Cancer Agents in Medicinal Chemistry;2021-09-03

5. Why bother with alpha particles?;European Journal of Nuclear Medicine and Molecular Imaging;2021-06-27